Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 3
2018 3
2019 7
2020 7
2021 10
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Gagelmann N, Badbaran A, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol F, Wolschke C, Robin M, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N. Gagelmann N, et al. Among authors: rautenberg c. Blood. 2023 Jun 8;141(23):2901-2911. doi: 10.1182/blood.2023019630. Blood. 2023. PMID: 36940410
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Schroeder T, Stelljes M, Christopeit M, Esseling E, Scheid C, Mikesch JH, Rautenberg C, Jäger P, Cadeddu RP, Drusenheimer N, Holtick U, Klein S, Trenschel R, Haas R, Germing U, Kröger N, Kobbe G. Schroeder T, et al. Among authors: rautenberg c. Haematologica. 2023 Nov 1;108(11):3001-3010. doi: 10.3324/haematol.2022.282570. Haematologica. 2023. PMID: 37259567 Free PMC article.
Improving the accuracy of prognostication in chronic myelomonocytic leukemia.
Kaivers J, Schuler E, Hildebrandt B, Betz B, Rautenberg C, Haas R, Kobbe G, Gattermann N, Germing U. Kaivers J, et al. Among authors: rautenberg c. Expert Rev Anticancer Ther. 2020 Aug;20(8):703-714. doi: 10.1080/14737140.2020.1796644. Epub 2020 Aug 6. Expert Rev Anticancer Ther. 2020. PMID: 32700646 Review.
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
Gagelmann N, Hobbs GS, Campodonico E, Helbig G, Novak P, Schroeder T, Schneider A, Rautenberg C, Reinhardt HC, Bosques L, Heuser M, Panagiota V, Thol F, Gurnari C, Maciejewski JP, Ciceri F, Rathje K, Robin M, Pagliuca S, Rubio MT, Rocha V, Funke V, Hamerschlak N, Salit R, Scott BL, Duarte F, Mitrus I, Czerw T, Greco R, Kröger N. Gagelmann N, et al. Among authors: rautenberg c. Am J Hematol. 2024 May;99(5):844-853. doi: 10.1002/ajh.27252. Epub 2024 Feb 15. Am J Hematol. 2024. PMID: 38357714
Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia.
Gagelmann N, Bogdanov R, Stölzel F, Rautenberg C, Panagiota V, Becker H, Radujkovic A, Luft T, Christopeit M, Finke J, Platzbecker U, Ditschkowski M, Schroeder T, Koldehoff M, Heuser M, Kobbe G, Beelen DW, Germing U, Kröger N. Gagelmann N, et al. Among authors: rautenberg c. Transplant Cell Ther. 2021 Jan;27(1):95.e1-95.e4. doi: 10.1016/j.bbmt.2020.10.007. Epub 2020 Oct 9. Transplant Cell Ther. 2021. PMID: 33039516 Free article.
32 results